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The ﬂavin mononucleotide in complex I (NADH:ubiquinone oxidoreductase) catalyzes NADH oxida-
tion, O2 reduction to superoxide, and the reduction of several ‘artiﬁcial’ electron acceptors. Here, we
show that the positively-charged electron acceptors paraquat and hexaammineruthenium(III) react
with the nucleotide-bound reduced ﬂavin in complex I, by an unusual ternary mechanism. NADH,
ATP, ADP and ADP-ribose stimulate the reactions, indicating that the positively-charged acceptors
interact with their negatively-charged phosphates. Our mechanism for paraquat reduction deﬁnes
a new mechanism for superoxide production by complex I (by redox cycling); in contrast to direct
O2 reduction the rate is stimulated, not inhibited, by high NADH concentrations.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Complex I (NADH:ubiquinone oxidoreductase) is an entry point
for electrons into the respiratory chains of mammalian mitochon-
dria and many other aerobic organisms. Complex I uses a ﬂavin
mononucleotide to oxidize NADH, then transfers the electrons to
bound ubiquinone through a series of iron–sulfur (FeS) clusters;
the redox potential energy is used to translocate protons across
the inner mitochondrial or cytosolic membrane [1]. Complex I is
also a signiﬁcant source of reactive oxygen species (ROS) [2], and
a major cause of mitochondrial and neuromuscular diseases, med-
iated by both decreases in catalytic capability and increases in ROS
production [3,4].
In complex I, NADH is oxidized in a hydride-transfer reaction,
with the nicotinamide ring juxtaposed above the ﬂavin isoalloxa-
zine system [5]. During turnover, the ﬂavin is reoxidized by the
FeS clusters. Alternatively, NAD+ dissociation exposes the reduced
ﬂavin to solvent and to molecular oxygen, leading to the physiolog-
ically-important side-reaction that generates superoxide [2,6,7]. In
vitro, the solvent-exposed, reduced ﬂavin may react with severalchemical Societies. Published by E
r; HAR, hexaamminerutheni-additional oxidants including potassium hexacyanoferrate(III) (fer-
ricyanide, FeCN) [8,9], hexaammineruthenium(III) (HAR), 3-
acetylpyridine adenine dinucleotide (APAD+, an NAD+ analogue)
[9,10], and hydrophilic quinones such as ubiquinone-0,1 and ideb-
enone [11]. FeCN, APAD+, O2 and the hydrophilic quinones all react
with ping-pong-type mechanisms [9–11]. It is generally accepted
that HAR does not react by a ping-pong-type mechanism
[9,12,13], but despite the mechanism of its reaction being un-
known it is widely used in studies of the complex I ﬂavin site.
Paraquat (N,N0-dimethyl-4,40-bipyridinium) is a widely used
herbicide that is toxic to many animals. It is taken up by mitochon-
dria (due to its positive charge and hydrophobicity) and reduced by
complex I, then reoxidized by O2 in redox-cycling reactions that
generate superoxide [14]. Redox-cycling is central to paraquat tox-
icity [15], and used to stimulate superoxide production in models
of oxidative stress and Parkinson’s disease [14,16]. Here, we
quickly established that the paraquat and HAR reactions display
similar characteristics, so they are likely to follow the same mech-
anism. Both molecules are positively charged, whereas all known
ping-pong-type reductants are either neutral or negatively
charged; the pH and ionic strength dependencies of the rates of
NADH:HAR and NADH:FeCN oxidoreduction support the idea that
charge determines the mechanism adopted [17,18].
Here, we deﬁne the mechanism of the NADH:HAR and
NADH:paraquat reactions, catalyzed by the ﬂavin in complex I.
We describe how both reactions are accelerated, not inhibited, bylsevier B.V. All rights reserved.
Fig. 1. Dependence of the rate of the HAR reaction on the NADH, nucleotide and HAR concentrations, and comparison with the FeCN reaction. (A) The effects of NADH
concentration on the HAR (, 1 mM HAR) and FeCN reactions (s, 0.5 mM FeCN, data from [9]). (B) The effects of ADP-ribose (s), ADP ( ) and ATP () on the HAR reaction
(100 lMNADH, 0.25 mM HAR). (C) The effects of NADH concentration on the HAR reaction (s, 0.25 mM HAR) in 0.75 mM ADP ( ) or 0.75 mM ATP (). (D) The effects of HAR
concentration on the HAR reaction (s, 100 lM NADH) in 0.75 mM ADP ( ) or 0.75 mM ATP (). Lines through the data points are included only as a guide. See Section 2 for
conditions.
Fig. 2. Dependence of the rate of the paraquat reaction on the NADH, nucleotide and paraquat concentrations, and comparison with the ﬂavin-catalyzed Q0-reaction. (A) The
effects of NADH concentration on the paraquat (, 0.25 mM paraquat) and ubiquinone-0 reactions (s, 0.25 mM Q0, data from [11]). (B) The effects of ADP-ribose (s), ADP ( )
and ATP () on the paraquat reaction (100 lMNADH, 0.25 mM paraquat). (C) The effects of NADH concentration on the paraquat reaction (s, 0.25 mM paraquat) in 4 mM ADP
( ) or 4 mM ATP (). (D) The effects of paraquat concentration on the paraquat reaction (s, 100 lM NADH) in 4 mM ADP ( ) or 4 mM ATP (). Lines through the data points
are included only as a guide. See Section 2 for conditions.
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NADH:HAR and NADH:FeCN reactions into a single analysis, to
build a uniﬁed picture of all the reactions catalyzed at the ﬂavin
site. Finally, our new and unusual ternary mechanism for a ﬂa-
vin-catalyzed oxidoreduction reaction reveals a route for ROS pro-
duction by complex I that is stimulated, not inhibited, by high
NADH concentrations.2. Materials and methods
Complex I was prepared from Bos taurus heart mitochondria as
described previously [19]. Kinetic assays were carried out in
20 mM Tris–HCl (pH 7.5, 32 C) using a Molecular Devices microti-
ter plate reader. All reagents were added from concentrated stock
solutions in assay buffer, and reactions were initiated by complex I
Scheme 1. Summary of reactions occurring at the ﬂavin site in complex I. (A)
Combined mechanism for all reactions localized to the ﬂavin in complex I. The
oxidized ﬂavin (Ox) binds and oxidizes NADH, and NAD+ is released (center). The
ﬂavin may be reoxidized by FeCN, APAD+, O2, or a hydrophilic quinone (blue).
Alternatively, it may bind a nucleotide (NADH, ATP, ADP or ADP-ribose) to inhibit
the FeCN, APAD+, O2, or hydrophilic-quinone reactions, but activate the HAR or
paraquat reactions (green). HAR or paraquat may also react before NAD+ dissociates
(red). When ATP, ADP or ATP-ribose bind to Ox every reaction is inhibited. (B)
Matching scheme for complex I in the mitochondrion, depicting the three
equivalent pathways for NADH oxidation coupled to ﬂavin reoxidation by the FeS
clusters, and the three possible mechanisms of ROS production; the two ‘courier
molecule’ mechanisms are exempliﬁed by paraquat and Q0.
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were calculated using linear regression; background rates (without
complex I) were subtracted. The NADH:APAD+ reaction was moni-
tored at 400–450 nm (e = 3.16 mM1 cm1) [10], all other reactions
at 340–380 nm (e = 4.81 mM1 cm1) [9]. Each data point is the
mean average of three independent measurements; standard devi-
ations were always <10% of the average value. Data were modeled
by optimizing ﬁts with values calculated using steady-state equa-
tions as described previously [9,10].
3. Results and discussion
3.1. The NADH concentration dependence of the NADH:HAR and
NADH:paraquat reactions
Fig. 1A presents two comparable datasets from the NADH:HAR
and NADH:FeCN oxidoreduction reactions (the HAR and FeCNreactions). They both display high maximum rates (1000 s1),
but depend very differently on NADH concentration. The rate of
the FeCN reaction peaks at 30 lM NADH [9], whereas that of
the HAR reaction increases steadily to a plateau. Similarly,
Fig. 2A compares two datasets from the NADH:paraquat and
NADH:Q0 oxidoreduction reactions (the paraquat and Q0 reac-
tions). The rate of the paraquat reaction was measured from the
rate of NADH oxidation; under aerobic conditions the colored para-
quat radical is not observed because it is rapidly reoxidised by O2
to form superoxide. Figs. 1 and 2A reveal clear differences between
the ping-pong-type FeCN and Q0 reactions, and the paraquat and
HAR reactions. In addition, data from the FeCN and HAR reactions
cannot be modeled together using the same mechanism and
NADH-dependent parameters ([9] and see below). Therefore, HAR
(and paraquat) do not react predominantly with the nucleotide-
free reduced ﬂavin in ping-pong-type reactions. They may react
with the nucleotide-bound reduced ﬂavin, one of the FeS clusters,
or at the quinone-binding site. Because the HAR and paraquat reac-
tions are not inhibited by the canonical ‘Q-site’ inhibitors rotenone
or piericidin A, and the HAR reaction is catalyzed by the ﬂavopro-
tein subcomplex of complex I [12,13], the nucleotide-bound ﬂavin
or the 2Fe[24] or 4Fe[51] clusters are the best candidates. Intrigu-
ingly, Fig. 1A in particular indicates that the decreasing rate of the
FeCN reaction with NADH concentration mirrors the increasing rate
of the HAR reaction, suggesting that the same species (perhaps the
NADH-bound reduced ﬂavin) both inhibits the FeCN reaction and
enables the HAR reaction.
3.2. Inhibition and activation by ATP, ADP and ADP-ribose
Fig. 1B shows that the HAR reaction is stimulated signiﬁcantly
by ATP (200% maximum) and ADP (125%), but only slightly by
ADP-ribose (105%); Fig. 2B reveals similar effects on the paraquat
reaction (ATP and ADP 325%, ADP-ribose 115%). Most obviously
for the HAR reaction, low nucleotide concentrations stimulate the
reactions but high nucleotide concentrations inhibit them – pro-
ducing a maximum rate at intermediate concentrations. The ‘play
off’ between activation and inhibition suggests that the nucleotides
activate one step of the reaction but inhibit another. Simple inhibi-
tion of the FeCN, APAD+ and O2 reactions by ADP-ribose has been
described previously: ADP-ribose binds strongly to the oxidized
ﬂavin and competes against NADH binding [9,20]. Inhibition of
the FeCN reaction by ADP and ATP has also been noted [21], and
was conﬁrmed (along with inhibition of the APAD+ and O2 reac-
tions) during this study (data not shown). Thus, inhibition of the
HAR and paraquat reactions by high concentrations of ATP, ADP
and ADP-ribose is ascribed to their inhibiting NADH binding to
the oxidized ﬂavin – and the stimulation of the reactions by lower
concentrations is ascribed to their stimulating HAR and paraquat
reduction. Paraquat reduction is much slower than HAR reduction,
so the paraquat reaction is more easily stimulated and less easily
inhibited.
Figs. 1 and 2C show that the effective KM for NADH in the HAR
and paraquat reactions is decreased by ADP and ATP. ATP and ADP
activate best at low NADH concentrations, suggesting that para-
quat and HAR reduction depend on sufﬁcient nucleotide being
present, and that NADH, ADP, ATP (and ADP-ribose) can all fulﬁll
the same role. ATP activates best, probably because of its extra neg-
ative charge (at high NADH concentrations the NADH-bound
reduced ﬂavin is less reactive than the ATP-bound reduced ﬂavin).
Figs. 1 and 2D reveal typical saturation-type kinetics for the depen-
dence of rate on paraquat and HAR concentration: the rates grad-
ually attain the maximum values that the nucleotide-occupancy
of the active site can support.
In summary, we propose that ADP, ATP and ADP-ribose bind to
the oxidized ﬂavin and inhibit NADH oxidation; when NADH, ADP,
Fig. 3. Combination modeling of data from the HAR and FeCN reactions. (A) Three possible reaction mechanisms for NADH oxidation coupled to HAR reduction by the ﬂavin
in complex I, and the steady-state equations for each pathway. The main scheme shows the NADH- and NAD+-dependent steps that are common to all the mechanisms
(black), including the diagonal hydride-transfer reaction. The three possible mechanisms of HAR reduction (ﬂavin oxidation) are colored on the main scheme, and the
complete NADH:HAR oxidoreduction reaction schemes for each of them are denoted by the colored insets (the reaction pathways are marked by solid lines, inhibitory steps
by dotted lines). Green: oxidation of NADH-bound ﬂavin; blue, oxidation of unbound ﬂavin (ping-pong-type pathway applied to FeCN); red: oxidation of NAD+-bound ﬂavin.
N: NADH concentration, H: HAR concentration, E: enzyme concentration. K1, K6 and K7 are dissociation constants, K2 = k2/k2. (B) Dependence of the rate of the HAR reaction
on NADH concentration ( 2 mM, 1 mM, s 0.5 mM HAR) modeled with the green equation. (C) Dependence of the rate of the FeCN reaction on NADH concentration (
1 mM, 0.5 mM, s 0.2 mM FeCN) modeled with the blue equation (with H = FeCN concentration). Parameters: K1 = 20 lM, k1 = 1.6  108 M1 s1, K2 = 0.67,
k2 = 3.0  104 s1, k3 = 8000 s1, K6 = 10 lM, K7 = 70 lM, k7 = 3.3  107 M1 s1, k4F = k5F = 2.6  107 M1 s1 (FeCN), k12H = k13H = 4.0  106 M1 s1 (HAR).
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quat and HAR reduction, but inhibit FeCN, APAD+ and O2 reduction.
AMP and GDP show similar effects, but pyrimidine nucleotides
such as CDP and UDP do not (data not shown) – they do not bind
effectively to complex I because they are unable to mimic the
hydrophobic interactions of the adenine moiety of NADH/NAD+
with three conserved phenylalanines [5]. It is likely that the posi-
tively-charged paraquat and HAR interact with the enzyme:nucle-
otide complex at the negatively-charged patch created by the
nucleotide phosphates. Adenosine, which lacks phosphates, does
not stimulate the reaction (data not shown), and the general
decrease of the rate of the HAR reaction with increasing ionic
strength [18] is consistent with an interaction between oppo-
sitely-charged species. Finally, probing the nucleotide-bound
structure [5] with a 3.6 Å diameter (HAR-sized) probe [9] con-
ﬁrmed that HAR is able to contact the solvent-exposed oxygens
of the nucleotide phosphates, to approach to within 12.8 Å of the
ﬂavin ring system, close enough for fast, direct electron transfer.
3.3. The ternary mechanism of HAR and paraquat reduction
Scheme 1A presents our uniﬁed picture for the reactions cata-
lyzed by the ﬂavin in complex I. The reactions of NADH and
NAD+, which are common to all the reactions, are shown in thecentre. All the neutral and negatively-charged acceptors react by
ping-pong-type mechanisms (on the left side of Scheme 1A),
whereas all the positively-charged acceptors react by the new
mechanism described here (on the right side of Scheme 1A). Wur-
sters’s Blue (the radical cation of N,N,N0,N0-tetramethyl-p-phenyl-
enediamine) also probably reacts by our new mechanism (see
data in [22]). A similar scheme is shown in Fig. 3A, but without
additional nucleotides, and with the parameters deﬁned for each
step. The three possible mechanisms for HAR reduction are shown
in green (HAR reacts with the NADH-bound ﬂavin), blue (with the
unbound ﬂavin) and red (with the NAD+-bound ﬂavin); the hydride
transfer (OxNADH to RedNAD+, diagonal) is common to all. The
blue pathway (the steps from the main scheme that are involved
are depicted by the blue inset, with the inhibitory steps dotted)
is the ping-pong-type mechanism described previously for the
FeCN and O2 reactions [9], but with NADH oxidation described
by NADH binding, hydride transfer, and NAD+ dissociation (not
by the Michaelis–Menten equation). The steady-state equations
for each pathway are presented also in Fig. 3A; the red pathway
has zero rate, as the system becomes trapped in the unreactive
Red/Semi and RedNADH/SemiNADH states.
A combined modeling approach [9–11] was adopted: the blue
equation was used to model data from the FeCN reaction, and
either the blue or green equation to model data from the HAR
2322 J.A. Birrell et al. / FEBS Letters 585 (2011) 2318–2322reaction; common values were used for the NADH-dependent
parameters that appear in both equations. No ﬁt could be obtained
when the HAR data were modeled with the blue (ping-pong-type)
equation, but good ﬁts were obtained with the green equation
(Fig. 3B and C). This result strongly supports our proposal that
HAR (and paraquat) react with the nucleotide-bound reduced ﬂa-
vin in complex I. Further analyses are detailed in the Supplemen-
tary Information. They showed that HAR may react with both the
NADH- and NAD+-bound ﬂavin (including both pathways improves
the ﬁt) but not with the unbound ﬂavin, and that data from the
HAR, FeCN, APAD+ and O2 reactions [9] may all be combined into
a single ﬁt. Furthermore, if all three HAR reduction pathways were
included in the modeling, with the same rate constants, then no ﬁt
to the data could be obtained, providing further evidence that HAR
does not react at a distant site that is independent of the ﬂavin. Fi-
nally, we explored the possibility of deﬁning values for some of the
unknown parameters, but this was not possible because of the
complexity of the mechanism and the number of parameters.
The HAR and paraquat reactions are ternary reactions, because
the reactive complex comprises enzyme, nucleotide and oxidant.
The mechanism appears to be unique in that hydride transfer from
NADH to ﬂavin is followed by electron transfer from the ﬂavin,
‘back across’ the bound nucleotide, with the binding site for the
oxidant constituted directly by the bound reductant. Our mecha-
nism shows limited similarity with mechanisms suggested previ-
ously [12,13]; in particular, Sled and Vinogradov proposed that
HAR oxidizes the reduced ﬂavin while NAD+ is bound, but from a
distant site, not one so intimately connected to the ﬂavin.
3.4. How the mechanistic versatility of the ﬂavin relates to complex I in
the mitochondrion
Scheme 1B mirrors Scheme 1A, except that it describes reac-
tions in the mitochondrion, during catalysis (when the ﬂavin is
reoxidized by the FeS clusters) and during ROS production. Follow-
ing NADH oxidation, three pathways (blue, red, and green, as in
Scheme 1A) return the system to OxNADH, depending on the sub-
strate concentrations and conditions. For example, when oxidized
ubiquinone is available and the proton-motive force is low, turn-
over is fast: ﬂavin oxidation outcompetes NAD+ dissociation and
the red pathway is favored. Conversely, the green pathway is fa-
vored when the NAD+ pool is highly reduced and turnover is slow;
it combines re-oxidation of the most potent reductant (RedNADH)
with minimization of the Red state that reduces O2 directly [6,7,9].
ROS production by redox cycling from the reduction of neutral (or
negatively-charged) ‘courier’ molecules such as Q1, Q0 or idebe-
none [11] is minimized similarly. However, ROS production by re-
dox cycling driven by the reduction of positively-charged ‘courier’
molecules such as paraquat is not blocked under these conditions,
it is accelerated. Our ternary-mechanism of ROS production thus
presents a much greater oxidative challenge when the NAD+ pool
is highly reduced, revealing one of the reasons why paraquat is
so toxic to mitochondria. Whether ROS production by complex I,
mediated by courier molecules and redox-cycling reactions (as
the undesirable side effects of pharmaceutical agents), is of wider
physiological importance remains to be conﬁrmed.
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